SR 27897
CAS: 136381-85-6
Rif. 3D-LFA38185
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta | ||
100mg | Prezzo su richiesta |
Informazioni sul prodotto
- (2-{[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl}-1H-indol-1-yl)acetic acid
- 1H-Indole-1-acetic acid, 2-[[[4-(2-chlorophenyl)-2-thiazolyl]amino]carbonyl]-
- 2-(2-((4-(2-Chlorophenyl)thiazol-2-yl)carbamoyl)-1H-indol-1-yl)acetic acid
- 2-[2-[[4-(2-Chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]acetic acid hydrate
- 2-[[N-[4-(2-Chlorophenyl)-2-thiazolyl]amino]carbonyl]-1H-indole-1-acetic acid
- 2-[[[4-(2-Chlorophenyl)-2-thiazolyl]amino]carbonyl]-1H-indole-1-acetic acid
- Lintitript
- Sr 27897B
- Sr-27897
- [2-[4-(2-Chloro-phenyl)-thiazol-2-ylcarbamoyl]-indol-1-yl]-acetic acid
- Vedi altri sinonimi
SR 27897 is a novel, non-peptide, orally active agent that selectively activates the receptor for substance P. Animal studies have shown that SR 27897 has a hypoglycemic effect and can reduce food intake. The drug binds to the receptor for substance P and inhibits the release of acetylcholine from nerve terminals in the bladder, which may be due to its ability to release melatonin from pineal gland cells. It is also thought that SR 27897 may have therapeutic potential in treating cancer.
Proprietà chimiche
Richiesta tecnica su: 3D-LFA38185 SR 27897
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.